All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Patients with 22q11.2 deletion syndrome (22q11.2DS) present specific conotruncal defects \[[@pone.0211170.ref001],[@pone.0211170.ref002], [@pone.0211170.ref003]\] including tetralogy of Fallot with or without pulmonary atresia \[[@pone.0211170.ref004], [@pone.0211170.ref005]\], Truncus Arteriosus \[[@pone.0211170.ref006], [@pone.0211170.ref007]\], Interrupted Aortic Arch \[[@pone.0211170.ref008], [@pone.0211170.ref009]\], other aortic arch anomalies or minor congenital heart defects \[[@pone.0211170.ref010], [@pone.0211170.ref011]\], and ventricular septal defect \[[@pone.0211170.ref012]\].

In more than 90% of them a 3 Mb deletion was detected \[[@pone.0211170.ref013]\], spanning LCR22-A to LCR22-D that contains at least 30 genes including *TBX1* in the proximal region. This encodes a T-box transcription factor identified as the major player of this syndrome throughout both modeling mice \[[@pone.0211170.ref014]--[@pone.0211170.ref017]\] and mutational analysis in patients \[[@pone.0211170.ref018]\]. In *Tbx1* mutant mice some cardiovascular anomalies similar to those found in 22q11.2DS patients have been described \[[@pone.0211170.ref015], [@pone.0211170.ref019]\]. These observations can be explained by the fact that *Tbx1* is expressed in precursors of outflow tract cells and its loss of function reduces cell contribution to the outflow tract \[[@pone.0211170.ref020]--[@pone.0211170.ref022]\].

Additional anomalies of pulmonary arteries (PAs) including diffuse hypoplasia, discontinuity, and crossing, were sporadically reported in 22q11.2DS patients \[[@pone.0211170.ref001], [@pone.0211170.ref003], [@pone.0211170.ref023]--[@pone.0211170.ref026]\] but not extensively studied. The aim of this study is to investigate the dimensions of both PAs in patients with this syndrome. In addition, we have analyzed the PAs diameters in *Tbx1* knockout mice and found that its haploinsufficiency is associated with PAs asymmetry, indicating that this gene is the candidate for the PA phenotype reported here.

Materials and methods {#sec006}
=====================

This is a prospective multicentric observational and experimental study conducted in three different Italian Centers: Department of Pediatrics, Sapienza University of Rome, Bambino Gesù Children's Hospital and Research Institute, and Institute of Genetics and Biophysics of National Research Council, Naples.

Mouse studies were carried out at the Institute of Genetics and Biophysics under the auspices of the animal protocol 257/2015-PR (licensed to the AB lab) reviewed, according to Italian regulations, by the Italian Istituto Superiore di Sanità and approved by the Italian Ministero della Salute. The laboratory applies the \"3Rs\" principles to minimize the use of animals and to limit or eliminate suffering.

Echocardiographic study {#sec007}
-----------------------

Patients data were collected from our hospital database of patients attending the Pediatric Cardiology Division of Sapienza University and Bambino Gesù Children Hospital from October 2010 to April 2017. Informed consent was obtained from each patient (or legal guardians). The echocardiographic measurements are derived from routine ultrasound exams. The study conforms to the ethical guidelines of the 1975 Declaration of Helsinki.

We included 58 pediatric and adult patients with 22q11.2DS without intracardiac malformations. Six of them presented isolated non-obstructive abnormalities of aortic arch or epiaortic vessels. We excluded from our cohort subjects with cardiac defects because of possible flow-related bias in our PAs measurements. The group of 58 cases consisted of 23 females (39.6%) and 35 males (60.4%), mean age of 12.8 ±10 years, with a mean body surface area (BSA) of 1.17±0.5; our control group consisted of 54 subjects (41% females) with a mean age of 10.8 ±10 years and a mean BSA of 1.18±0.5.

All patients underwent genetic counseling, and fluorescent in situ hybridization was performed to confirm the specific microdeletion. Echocardiographic measurements were compared with healthy subjects matched for age, sex, and BSA. All patients and healthy controls underwent a complete transthoracic echocardiographic examinations using GE Vivid E9 (Medical Systems, Oslo, Norway) with M6SD and 7S convex probe and Philips Ie33 Machine (Philips Medical Systems, Andover, MA) with X-5 and X-7 probes. M Mode, 2-Dimensional, and Doppler examinations were performed in all subjects. In particular, pulmonary branches were measured in parasternal short axis view during systole. Aortic arch anomalies were diagnosed in jugular view. According to BSA, Z score values were reported for M Mode results and for 2D PA branches diameters. Images were digitally stored and measurement were made offline according to the American Society of Echocardiography guidelines by two independent readers for both centers (GM, PV, and GC, EP).

Mouse studies {#sec008}
-------------

To perform phenotypic analyses, *Tbx1*^*+/-*^ mice \[[@pone.0211170.ref015]\] were intercrossed and pregnant females (3--6 months-old) were sacrificed using CO~2~ inhalation at plug day (E) 18.5, and fetuses harvested. Prior to observation. fetuses were washed in PBS and dissected under a Zeiss Stemi 2000-CS Stereo Microscope. Photographs were taken using a Z-stack software. In order to improve the view, we injected ink into the pulmonary trunk. Overall we have dissected and examined the cardiovascular phenotype of 8 wild type (WT), 37 heterozygous (*Tbx1*^+/-^), and 6 null fetuses (*Tbx1*^-/-^). PA measurements (in pixels) were taken from good quality images at the same magnification using software tools. Statistical significance was evaluated using the Mann-Withney test. To reveal *Tbx1*-expressing cells and their descendants, we crossed *Tbx1*^*Cre*/+^ mice \[[@pone.0211170.ref027]\] with *Rosa*^*mT*-*mG*^ mice a Cre reporter \[[@pone.0211170.ref028]\]. Hearts of E18.5 *Tbx1*^*Cre*/+^; *Rosa*^*mT*-*mG*^ embryos were dissected, photographed whole mount under Stemi 2000-CS Stereo Microscope with epifluorescence illumination, and then processed for cryosectioning. Sections were immunostained with an anti PECAM1 antibody (mouse monoclonal 2H8, Thermo Fisher MA3105, diluted 1:200) and/or an anti GFP antibody (Abcam ab13970, 1:800) as described elsewhere \[[@pone.0211170.ref021]\]. Sections were photographed using a Leica fluorescence microscope. Digital images were mounted using Photoshop to generate the figures shown here.

Results {#sec009}
=======

22q11.2DS patients have smaller LPAs than controls, independently from intracardiac anomalies {#sec010}
---------------------------------------------------------------------------------------------

We identified 58 patients with isolated abnormalities of aortic arch or epiaortic vessels disease according to our criteria. [Table 1](#pone.0211170.t001){ref-type="table"} summarizes major clinical findings. All 22q11.2DS patients had variable expressivity and incomplete penetrance of dysmorphic features typical of the syndrome. A similar group of healthy volunteers was analyzed ([Table 2](#pone.0211170.t002){ref-type="table"}). Using echocardiography, we have measured the diameter of PAs in a healthy subgroup and we found that LPAs were smaller than RPAs (9.4± 2.4 vs 10.0±2.8. P \< 0.05). This finding was confirmed also in in 22q11.2DS cases, which exhibited LPAs measurements smaller than RPAs (8.2± 2.4 vs 9.4±2.4; P = 0.016) and in Z score (-1.57± 1.2 vs -0.65± 1.0; P\<0.001). No differences were found comparing diameters of RPAs in cases and controls. In contrast, LPA/RPA ratios showed a significant difference between the two groups: 0.80±0.09 in cases vs 0.95±0.11 in controls (P \< 0.001) (Tables [1](#pone.0211170.t001){ref-type="table"} and [2](#pone.0211170.t002){ref-type="table"}).

10.1371/journal.pone.0211170.t001

###### Echocardiographic data of 22q11.2DS patients without intracardiac defects.

![](pone.0211170.t001){#pone.0211170.t001g}

  Case     Sex   Ao Arch Anomalies           PAs Anomalies   Age   Weight (kg)   High (cm)   BSA    LPA d   z-score LPA   RPA d   z-score RPA   LPA/RPA
  -------- ----- --------------------------- --------------- ----- ------------- ----------- ------ ------- ------------- ------- ------------- ---------
  **1**    M                                 CPAs            0     8             79          0.42   3.9     -2.95         4.1     -3.43         0.95
  **2**    M                                                 1     8.7           80          0.44   4.7     -2.03         5.7     -1.63         0.82
  **3**    F                                                 1     10            72          0.46   7.7     0.8           8       0.29          0.96
  **4**    F                                                 1     9.7           75          0.46   5.4     -1.32         6.8     -0.7          0.79
  **5**    F     RAA                                         2     12            83          0.53   7.8     0.29          9.3     0.56          0.84
  **6**    M                                                 2     8.5           80          0.44   5.4     -1.15         6.6     -0.69         0.82
  **7**    M                                                 2     13            86          0.56   6.6     -0.93         7.9     -0.67         0.84
  **8**    M                                 CPAs            2     11            83          0.51   5       -2.19         10      1.2           0.50
  **9**    F     RAA, Retroesophageal ARSA                   3     14            93          0.6    6.1     -1.67         6.8     -1.87         0.90
  **10**   F                                                 3     13            95          0.59   5.4     -2.28         6.3     -2.21         0.86
  **11**   M                                                 4     17            100.3       0.69   9.1     0.24          10      -0.04         0.91
  **12**   M                                                 4     28            107         0.93   5.7     -3.47         7.8     -2.47         0.73
  **13**   F                                                 4     16            100         0.67   5.6     -2.55         6.5     -2.53         0.86
  **14**   F                                                 4     12.4          93          0.57   5.4     -2.15         6.5     -1.88         0.83
  **15**   M     DAA                                         4     15            102         0.65   6.6     -1.47         8.3     -0.94         0.80
  **16**   M                                                 4     17            106         0.71   5.4     -2.96         8.4     -1.18         0.64
  **17**   M                                                 4     18            101         0.72   7.3     -1.2          9.2     -0.67         0.79
  **18**   F     Retroesophageal ARSA                        5     15.5          105         0.67   5.8     -2.38         6.9     -2.18         0.84
  **19**   M     RAA, Retroesophageal ALSA                   5     28            115         0.96   7.6     -1.82         8.3     -2.16         0.92
  **20**   F                                                 5     13            97          0.59   7.2     -0.59         7.6     -1.1          0.95
  **21**   F                                                 5     18            108         0.73   7       -1.54         9       -0.89         0.78
  **22**   M                                                 7     25.5          118         0.92   6.2     -2.94         7.2     -2.93         0.86
  **23**   M                                                 8     43            142         1.31   7.6     -2.38         10      -1.62         0.76
  **24**   F                                                 8     22.6          115         0.85   6.7     -2.27         10      -0.72         0.67
  **25**   F     Retroesophageal ARSA                        9     31            132         1.07   12      0.67          12      -0.15         1.00
  **26**   M     RAA                                         9     30            128         1.01   6.8     -2.61         8.2     -2.36         0.83
  **27**   M                                                 9     35            138         1.16   7.9     -1.98         11      -0.83         0.72
  **28**   F                                                 9     46            148         1.38   9.9     -0.87         13      -0.12         0.76
  **29**   F     Retroesophageal ARSA                        10    35            138         1.16   7.9     -1.98         9.1     -1.99         0.86
  **30**   M                                                 10    34            134         1.13   9.4     -0.89         11      -0.78         0.85
  **31**   M                                                 11    41            145.5       1.29   7.5     -2.44         8.2     -2.8          0.91
  **32**   M                                                 11    39            138         1.23   8.8     -1.42         10      -1.51         0.88
  **33**   F     RAA                                         12    45            149         1.37   7       -2.93         8.8     -2.47         0.80
  **34**   M                                                 12    34            144         1.16   7.5     -2.29         9       -2.05         0.83
  **35**   M     RAA, ALSA                   CPAs            12    45            150         1.37   10      -0.8          14      0.35          0.71
  **36**   F                                                 13    16            100         0.67   6.1     -2.04         6.5     -2.53         0.94
  **37**   M                                 CPAs            13    57            154         1.5    13      0.73          15      0.47          0.87
  **38**   M     RAA, ALSA                                   14    54            163         1.56   8       -2.32         8.9     -2.76         0.90
  **39**   M                                 CPAs            15    55            170         1.6    8.3     -2.15         12.3    -0.9          0.67
  **40**   M                                                 15    51            170         1.54   8.9     -1.66         9.6     -2.25         0.93
  **41**   M                                                 16    50            166         1.51   8.3     -2.04         12      -0.83         0.69
  **42**   F                                                 18    54            161         1.55   7       -3.11         10      -2.04         0.70
  **43**   F                                                 19    63            166         1.71   10.61   -0.85         14.34   -0.32         0.74
  **44**   F                                                 19    66            167         1.76   11      -0.71         13.6    -0.81         0.81
  **45**   M                                                 19    59            152         1.59   9       -1.65         11      -1.55         0.82
  **46**   M                                                 19    70            160         1.78   9.6     -1.58         16      0.07          0.60
  **47**   M     RAA, ALSA                   CPAs            20    61            176         1.72   7       -3.34         13      -0.93         0.54
  **48**   M                                                 20    65            165         1.73   7       -3.37         8       -3.95         0.88
  **49**   M                                 CPAs            21    62            166.5       1.7    12      N.A.          13      N.A.          0.92
  **50**   F     RAA, ARSA                                   21    73            156         1.8    10      N.A.          14      N.A.          0.71
  **51**   M                                                 22    61.5          174         1.72   10      N.A.          13      N.A.          0.77
  **52**   M                                                 22    69            162         1.78   13.4    N.A.          12.7    N.A.          1.06
  **53**   M                                 CPAs            23    59.5          163         1.65   12.8    N.A.          13.2    N.A.          0.97
  **54**   F                                 CPAs            34    71            165         1.82   7       N.A.          13      N.A.          0.54
  **55**   F                                                 34    74            167         1.87   7       N.A.          12      N.A.          0.58
  **56**   F                                                 37    91            162         2.06   12      N.A.          16      N.A.          0.56
  **57**   M                                                 40    87            172         2.06   8       N.A.          13      N.A.          0.62
  **58**   M                                                 45    122           176         2.5    11.4    N.A.          17      N.A.          0.67

Abbreviations: Ao: aortic--PAs: pulmonary arteries; CPAs: crossed pulmonary arteries; DAA: double aortic arch; RAA: right aortic arch; ARSA: aberrant right subclavian artery; ALSA: aberrant left subclavian artery; ret: retroesophageal.

10.1371/journal.pone.0211170.t002

###### Echocardiographic data of control patients.

![](pone.0211170.t002){#pone.0211170.t002g}

  Case     Sex   Ao Arch Anomalies   PAs Anomalies   Age   Weight (kg)   High (cm)   BSA    LPA d   z-score LPA   RPA d   z-score RPA   LPA/RPA
  -------- ----- ------------------- --------------- ----- ------------- ----------- ------ ------- ------------- ------- ------------- ---------
  **1**    M                                         0     9             74          0.44   6.4     0.06          7.3     0.14          0.88
  **2**    M                                         1     12            82          0.53   6       -1.26         6.2     -1.89         0.97
  **3**    F                                         1     12.5          87          0.55   5.9     -1.54         6       -2.28         0.98
  **4**    F                                         1     5.7           70          0.33   9       2.88          8       1.58          1.12
  **5**    F                                         2     10.7          47          0.4    8       1.52          8.6     1.29          0.93
  **6**    M                                         2     15            110         0.67   7.2     -1.06         7.3     -1.84         0.99
  **7**    M                                         2     11.2          90          0.53   6       -1.22         6.8     -1.28         0.88
  **8**    M                                         3     15.5          95          0.64   7.5     -0.67         7.5     -1.53         1
  **9**    F                                         3     15.5          102         0.66   7.2     -1.01         7.5     -1.63         0.96
  **10**   F                                         3     14            90          0.6    6.7     -1.06         7.2     -1.47         0.93
  **11**   M                                         4     21            110         0.8    6.4     -2.37         6.8     -2.9          0.94
  **12**   M                                         4     19            106         0.75   9.6     0.28          9.8     -0.45         0.98
  **13**   F                                         4     15            98          0.64   7.6     -0.57         7.8     -1.26         0.97
  **14**   F                                         4     17            108         0.71   8.1     -0.56         8.6     -1.06         0.94
  **15**   M                                         4     14            103         0.63   6.2     -1.72         6.6     -2.21         0.94
  **16**   M                                         4     23            100         0.81   10.1    0.32          12.2    0.62          0.83
  **17**   M                                         3     18            104         0.72   7.9     -0.77         8.6     -1.12         0.92
  **18**   F                                         5     22            123         0.86   7.6     -1.55         7.5     -2.51         1.01
  **19**   M                                         5     29            126         1.01   9.7     -0.49         11.9    -0.09         0.81
  **20**   F                                         5     26            124         0.95   7.4     -1.95         7.7     -2.59         0.96
  **21**   F                                         5     20            117         0.8    8.5     -0.67         7.5     -2.3          1.13
  **22**   M                                         7     27            121         0.96   8.5     -1.1          10      -0.79         0.85
  **23**   M                                         8     27            138         1.01   8.4     -1.4          8.5     -2.2          0.99
  **24**   F                                         8     25.5          129         0.95   8.4     -1.21         7.9     -2.45         1.06
  **25**   F                                         9     32            128         1.07   7.4     -2.23         7.5     -3.02         0.99
  **26**   M                                         9     40            139         1.25   11      -0.11         11      -0.96         1
  **27**   M                                         9     30.8          138         1.08   8.5     -1.5          9.3     -1.7          0.91
  **28**   F                                         8     35            142         1.17   10.4    -0.35         13.2    0.26          0.79
  **29**   F                                         10    45            150         1.37   9.9     -0.86         9.9     -1.76         1
  **30**   M                                         11    66            162         1.74   12      -0.15         13.4    -0.81         0.89
  **31**   M                                         11    42            158         1.35   10      -0.78         11      -1.09         0.91
  **32**   M                                         11    42            140         1.28   12      0.37          13      0.01          0.92
  **33**   F                                         12    36            148         1.21   10      -0.63         11      -0.9          0.91
  **34**   M                                         12    41            150         1.3    11      -0.17         10      -1.61         1.1
  **35**   M                                         12    40            148         1.28   7.2     -2.68         7.4     -3.41         0.97
  **36**   F                                         13    72            168         1.84   13      0.09          12.8    -1.6          1.02
  **37**   M                                         14    48            164         1.47   13      0.68          10      -1.86         1.3
  **38**   M                                         14    59            170         1.67   9.5     -1.43         9       -2.98         1.05
  **39**   M                                         16    70            163         1.8    10      -1.6          12      -1.3          0.83
  **40**   M                                         16    60            175         1.7    9.3     -1.61         9.3     -2.9          1
  **41**   F                                         18    80            160         1.92   12      1.1           11      -1.9          1.09
  **42**   F                                         20    55            165         1.58   12.12   0.08          13.58   -0.24         0.89
  **43**   M                                         20    68            168         1.79   8       -2.68         8.6     -3.74         0.93
  **44**   M                                         20    67            172         1.79   10      -1.36         10      -2.83         1
  **45**   M                                         21    82            190         2.08   11      N.A.          9       N.A.          1.2
  **46**   F                                         22    85            165         2.00   7       N.A.          7.1     N.A.          0.98
  **47**   M                                         22    76            177         1.94   9.1     N.A.          10      N.A.          0.91
  **48**   M                                         21    63            170         1.73   9.8     N.A.          11      N.A.          0.89
  **49**   M                                         23    87            170         2.05   14      N.A.          15      N.A.          0.93
  **50**   F                                         33    58            170         1.65   12.69   N.A.          13.36   N.A.          0.95
  **51**   F                                         33    61            162         1.66   13      N.A.          14      N.A.          0.93
  **52**   F                                         38    78            170         1.94   13      N.A.          13.8    N.A.          0.94
  **53**   M                                         40    107           170         2.29   17      N.A.          16      N.A.          1.06
  **54**   M                                         45    90            178         2.13   17.1    N.A.          19      N.A.          0.9

Abbreviations: Ao: aortic---PAs: pulmonary arteries---RAA: right aortic arch--ARSA: aberrant right subclavian artery--DAA: double aortic arch--ALSA: aberrant left subclavian artery.

*Tbx1* haploinsufficiency is associated with smaller LPAs in mice {#sec011}
-----------------------------------------------------------------

*TBX1* is the candidate gene for many of the clinical and developmental features of 22q11.2DS patients including aortic arch anomalies and intracardiac anomalies. However, to our knowledge, anomalies of PAs in mouse mutants have not been reported to date. To understand whether loss of *Tbx1* may be a candidate also for the observed size asymmetry of the PAs, we measured them in *Tbx1*^+/+^, *Tbx1*^+/-^, and *Tbx1*^-/-^ E18.5 fetuses in a homogeneous congenic background C57Bl6/N. Results are plotted in [Fig 1](#pone.0211170.g001){ref-type="fig"}. In WT (*Tbx1*^+/+^) fetuses, we found no significant difference (Mann-Whitney test) in the diameters of LPAs and RPAs (ratio LPA/RPA = 0.92. n = 8). However, in *Tbx1*^+/-^ fetuses, the LPAs were significantly smaller than the RPAs (P = 0.0016, ratio LPA/RPA = 0.79, n = 37). Similarly, the *Tbx1*^-/-^ fetuses also had significantly different PAs (P = 0.004, ratio LPA/RPA = 0.63, n = 6). All WT fetuses had normal arch and epiaortic vessels. Of the 37 heterozygous animals analyzed, 14 had aberrant origin of the right subclavian artery (37.8%) of which, 2 had high aortic arch, 3 interrupted aortic arch type B, and 1 right aortic arch. All 6 *Tbx1*^-/-^ fetuses had truncus arteriosus, as previously described \[[@pone.0211170.ref015]\]. In all *Tbx1*^-/-^ fetuses the pulmonary arteries rose separately from the posterior wall of the arterial trunk proximal to the branches of aortic arch (Truncus Arteriosus---type II of Collett and Edwards or type A2 of Van Praagh).

![Pulmonary artery size in mouse fetuses.\
Distribution of pulmonary arteries measurements in WT, *Tbx1*^+/-^, and *Tbx1*^-/-^ fetuses at E18.5. n.s.: not significant; \*\*: P value \< 0.005, Mann-Whitney test. The data source used to generate this graph is in the Supporting Information [Table 1](#pone.0211170.t001){ref-type="table"}.](pone.0211170.g001){#pone.0211170.g001}

Tbx1-expressing cells contribute to structural components of the pulmonary arteries {#sec012}
-----------------------------------------------------------------------------------

To provide insights as to how *Tbx1* may affect the development of the PAs, we looked into the expression of the gene. To do this. we used genetic marking of *Tbx1*-expressing cells and their descendants in *Tbx1*^*cre*/+^; *Rosa*^*mT*/mG^ embryos in which these cells are marked by membrane-bound green fluorescent protein (GFP). At E10.5, the PAs connect the aortic sac (through the proximal end of the 6th pharyngeal arch arteries) to the lung buds. GFP+ cells were observed in the mesoderm adjacent to the arteries, in the adjacent dorsal pericardial wall, and in the inner, endothelial layer of the arteries ([Fig 2](#pone.0211170.g002){ref-type="fig"}). In the mature PAs at E18.5, the distribution of GFP+ cells were observed in the endothelial layer and in the outer mesenchymal tissue adjacent to the arteries ([Fig 3](#pone.0211170.g003){ref-type="fig"}). We did not observe contribution of GFP+ cells in the smooth muscle layer of the arteries, in contrast to the pulmonary trunk.

![*Tbx1* expression in mouse embryos.\
Transverse section of a E10.5 *Tbx1*^*cre*/+^; *Rosa*^*mT*/mG^ embryos immunostained with an anti GFP antibody (green). GFP positivity indicate cells that have expressed Cre recombinase. A, B, and C refer to 3 adjacent sections (cranial -\> caudal) that span the junction between the 6th pharyngeal arch arteries (PAAs) and the putative pulmonary arteries (PAs). PP: pharyngeal pouches; DPW: dorsal pericardial wall. Scale bar is 100 micrometers.](pone.0211170.g002){#pone.0211170.g002}

![Distribution of Tbx1-expressing cells and their descendants in mouse fetuses.\
A.B: Whole mount fluorescent photographs of the outflow region of a E18.5 *Tbx1*^*cre*/+^; *Rosa*^*mT*/mG^ fetus. A: external appearance. B: internal optical plane. Note the heavy contribution of GFP+ cells to the pulmonary myocardium, pulmonary trunk (PT) and pulmonary valves, but superficial contribution (endothelial and adventitial) to other great vessels, including the ductus arteriosus (DA). which appears to have a more dense endothelial contribution. aAo: ascending aorta. C: immunofluorescence of a transverse section of a E18.5 *Tbx1*^*cre*/+^; *Rosa*^*mT*/mG^. Anti GFP staining is shown in green, anti PECAM1 staining (endothelial-specific) is shown in red. DAPI staining (cell nuclei) is shown in blu. C\'-C\'\': green and red channels are shown separately. aAo: ascending aorta; PT: pulmonary trunk and pulmonary leaflets; LPA, RPA: left and right pulmonary arteries. Scale bar is 50 micrometers in A and B, 100 micrometers in C-C\".](pone.0211170.g003){#pone.0211170.g003}

Discussion {#sec013}
==========

The junction between LPA and DA is a crucial segment for the cardiovascular development and it is frequently affected in patients with conotruncal anomalies \[[@pone.0211170.ref029]--[@pone.0211170.ref032]\]. Also in healthy people a smaller diameters of the LPA was reported in comparison with the RPA. Moreover, malformations of the pulmonary arteries, in particular of the left, including stenosis, diffuse hypoplasia, discontinuity or crossing, are not unusual in children with 22q11.2DS with or without conotruncal defects \[[@pone.0211170.ref033], [@pone.0211170.ref034], [@pone.0211170.ref003], [@pone.0211170.ref035], [@pone.0211170.ref036], [@pone.0211170.ref025], [@pone.0211170.ref024], [@pone.0211170.ref037]\]. The detailed morphogenesis of the pulmonary arteries is not definitively ascertained. However, recent studies on mouse and human embryos contribute to better clarify this difficult topic \[[@pone.0211170.ref038], [@pone.0211170.ref039]\]. According to recent data, while on the right side the VI pharyngeal arch artery disappears, on the left side it is formed by a ventral bud from the aortic sac and by a dorsal bud from the dorsal aorta. This ventral bud, with the contribution from the post-branchial pulmonary plexus, forms the LPA. The dorsal bud on the left side of the VI aortic arch forms the ductus arteriosus (DA), which is in continuity with the LPA. Our echocardiographic studies show that even in the absence of conotruncal defects, patients with 22q11.2DS have a smaller LPA compared to healthy subjects.

Our data demonstrate that the LPA is smaller than the RPA in *Tbx1*^+/-^ fetuses but not in WT fetuses, indicating that *Tbx1* haploinsufficiency affects significantly the LPA size. Expression data indicate that structural components of the PAs (endothelium and adventitia) derive from *Tbx1*-expressing cells. This is also true for the DA, thus suggesting that Tbx1 is involved in the development or growth of this cardiovascular segment. Mouse data are in agreement with echocardiographic measurements on patients with 22q11.2DS.

It is of interest to note that in mice *Tbx1* haploinsufficiency affects the IV but not the VI aortic arch artery development \[[@pone.0211170.ref019], [@pone.0211170.ref040]\], while in *Tbx1*^-/-^ embryos the VI does not develop \[[@pone.0211170.ref019]\]. The phenotype that we have described here suggest that a) the absence of the VI aortic arches does not have a dramatic impact on PAs development, and b) the reduced size of the LPA is probably not secondary to abnormalities of the VI aortic arch. The finding that *Tbx1*-expressing cells contribute to structural component of the PAs provides a support for a direct, though limited role of *Tbx1* in determining the size of the PAs.

In the past, stenosis, diffuse hypoplasia or atresia of the proximal LPA was mainly ascribed to the extension of the ductal tissue into the LPA lumen. This pathogenetic mechanism known as "coarctation of the LPA" maintains its validity. However, our data suggest that molecular causes may influence the morphogenesis of this peculiar cardiovascular region, in particular the effect of *Tbx1* in this region may influence the morphology and dimensions of the LPA and its loss of function may cause some of its specific defects.

The reduced dimensions of LPA observed in our patients could be considered a subclinical sign associated with 22q11.2DS. We suggest that in subjects with 22q11.2DS the junction between the DA and the LPA may be at risk of hypoplasia or additional anomalies and deserves specific diagnostic investigation, also in patients with conotruncal defects.
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###### Measurements used to generate the graph shown in [Fig 1](#pone.0211170.g001){ref-type="fig"}.
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Click here for additional data file.
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